Literature DB >> 28131628

Latent variable analysis of positive and negative valence processing focused on symptom and behavioral units of analysis in mood and anxiety disorders.

Martin P Paulus1, Murray B Stein2, Michelle G Craske3, Susan Bookheimer3, Charles T Taylor2, Alan N Simmons2, Natasha Sidhu2, Katherine S Young3, Boyang Fan3.   

Abstract

BACKGROUND: Mood and anxiety disorders are highly heterogeneous and their underlying pathology is complex. The Research Domain Criteria (RDoC) approach seeks to establish dimensionally and neuroscience-based descriptions of psychopathology that may inform better classification and treatment approaches. The current investigation sought to determine the latent variables underlying positive and negative valence processing in terms of symptoms and behavioral units of analysis.
METHOD: As part of an ongoing study, individuals with mood and anxiety problems were recruited largely from primary care clinics at UCLA (n=62) and UCSD (n=58). These participants underwent a comprehensive symptomatic and behavioral assessment. An implicit approach avoidance task and a modified dot probe detection task were used to measure positive and negative valence processing.
RESULTS: Principal components analysis with varimax rotation identified four symptom components, three behavioral components for the dot probe task, and two behavioral components for the implicit approach avoidance task. These components yielded two meta-components consisting of: negative valence symptoms, negative approach bias, and high sustained, selective attention; and positive valence symptoms, positive approach bias, and slow selective or sustained attention. The components did not differ between males and females, nor by age or medication status. LIMITATIONS: The limitations are: (1) relatively small sample, (2) exploratory analysis strategy, (3) no test/re-test data, (4) no neural circuit analysis, and (5) limited reliability of behavioral data.
CONCLUSIONS: These preliminary data show that positive and negative valence processing domains load on independent dimensions. Taken together, multi-level assessment approaches combined with advanced statistical analyses may help to identify distinct positive and negative valence processes within a clinical population that cut across traditional diagnostic categories.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety disorders; Mood disorders; Negative valence processing; Positive valence processing; Principal components analysis; Research domain criteria

Mesh:

Year:  2017        PMID: 28131628      PMCID: PMC5471118          DOI: 10.1016/j.jad.2016.12.046

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  91 in total

1.  Abstract reward and punishment representations in the human orbitofrontal cortex.

Authors:  J O'Doherty; M L Kringelbach; E T Rolls; J Hornak; C Andrews
Journal:  Nat Neurosci       Date:  2001-01       Impact factor: 24.884

Review 2.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

Authors:  Harvey A Whiteford; Louisa Degenhardt; Jürgen Rehm; Amanda J Baxter; Alize J Ferrari; Holly E Erskine; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Nicole Johns; Roy Burstein; Christopher J L Murray; Theo Vos
Journal:  Lancet       Date:  2013-08-29       Impact factor: 79.321

3.  Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal.

Authors:  T A Brown; B F Chorpita; D H Barlow
Journal:  J Abnorm Psychol       Date:  1998-05

4.  A brief measure for assessing generalized anxiety disorder: the GAD-7.

Authors:  Robert L Spitzer; Kurt Kroenke; Janet B W Williams; Bernd Löwe
Journal:  Arch Intern Med       Date:  2006-05-22

5.  Malleability of attentional bias for positive emotional information and anxiety vulnerability.

Authors:  Charles T Taylor; Jessica Bomyea; Nader Amir
Journal:  Emotion       Date:  2011-02

6.  Cognitive and emotional biomarkers of melancholic depression: An iSPOT-D report.

Authors:  Claire V Day; Justine M Gatt; Amit Etkin; Charles DeBattista; Alan F Schatzberg; Leanne M Williams
Journal:  J Affect Disord       Date:  2015-02-07       Impact factor: 4.839

7.  Neural correlates of social approach and withdrawal in patients with major depression.

Authors:  Birgit Derntl; Eva-Maria Seidel; Simon B Eickhoff; Thilo Kellermann; Ruben C Gur; Frank Schneider; Ute Habel
Journal:  Soc Neurosci       Date:  2011-07-21       Impact factor: 2.083

Review 8.  Whether, how, and when social anxiety shapes positive experiences and events: a self-regulatory framework and treatment implications.

Authors:  Todd B Kashdan; Justin W Weeks; Antonina A Savostyanova
Journal:  Clin Psychol Rev       Date:  2011-04-01

Review 9.  Differentiating the mood and anxiety disorders: a quadripartite model.

Authors:  David Watson
Journal:  Annu Rev Clin Psychol       Date:  2009       Impact factor: 18.561

10.  A comparison of direct versus self-report measures for assessing physical activity in adults: a systematic review.

Authors:  Stéphanie A Prince; Kristi B Adamo; Meghan E Hamel; Jill Hardt; Sarah Connor Gorber; Mark Tremblay
Journal:  Int J Behav Nutr Phys Act       Date:  2008-11-06       Impact factor: 6.457

View more
  8 in total

1.  A tale of two systems: Testing a positive and negative valence systems framework to understand social disconnection across anxiety and depressive disorders.

Authors:  Charles T Taylor; Sarah L Pearlstein; Murray B Stein
Journal:  J Affect Disord       Date:  2020-01-13       Impact factor: 4.839

2.  Same same, but different: A psychometric examination of three frequently used experimental tasks for cognitive bias assessment in a sample of healthy young adults.

Authors:  Alla Machulska; Kristian Kleinke; Tim Klucken
Journal:  Behav Res Methods       Date:  2022-06-01

3.  Mapping Research Domain Criteria using a transdiagnostic mini-RDoC assessment in mental disorders: a confirmatory factor analysis.

Authors:  Bernd R Förstner; Mira Tschorn; Nicolas Reinoso-Schiller; Lea Mascarell Maričić; Erik Röcher; Janos L Kalman; Sanna Stroth; Annalina V Mayer; Kristina Schwarz; Anna Kaiser; Andrea Pfennig; André Manook; Marcus Ising; Ingmar Heinig; Andre Pittig; Andreas Heinz; Klaus Mathiak; Thomas G Schulze; Frank Schneider; Inge Kamp-Becker; Andreas Meyer-Lindenberg; Frank Padberg; Tobias Banaschewski; Michael Bauer; Rainer Rupprecht; Hans-Ulrich Wittchen; Michael A Rapp
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-07-01       Impact factor: 5.270

4.  Distress and anhedonia as predictors of depression treatment outcome: A secondary analysis of a randomized clinical trial.

Authors:  Gabriela K Khazanov; Colin Xu; Barnaby D Dunn; Zachary D Cohen; Robert J DeRubeis; Steven D Hollon
Journal:  Behav Res Ther       Date:  2019-10-31

5.  Failure to Identify Robust Latent Variables of Positive or Negative Valence Processing Across Units of Analysis.

Authors:  Yujia Peng; Jeffrey D Knotts; Charles T Taylor; Michelle G Craske; Murray B Stein; Susan Bookheimer; Katherine S Young; Alan N Simmons; Hung-Wen Yeh; Julian Ruiz; Martin P Paulus
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-03-03

6.  Age-Related Enhancements in Positive Emotionality across The Life Span: Structural Equation Modeling of Brain and Behavior.

Authors:  Jason Stretton; Susanne Schweizer; Tim Dalgleish
Journal:  J Neurosci       Date:  2022-03-07       Impact factor: 6.709

7.  Affective dynamics among veterans: Associations with distress tolerance and posttraumatic stress symptoms.

Authors:  Jeffrey S Simons; Raluca M Simons; Kevin J Grimm; Jessica A Keith; Scott F Stoltenberg
Journal:  Emotion       Date:  2020-03-19

Review 8.  Can an Integrated Science Approach to Precision Medicine Research Improve Lithium Treatment in Bipolar Disorders?

Authors:  Jan Scott; Bruno Etain; Frank Bellivier
Journal:  Front Psychiatry       Date:  2018-08-21       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.